Primary experience with an active fixation coronary sinus lead for cardiac resynchronization therapy

ZHOU Jing,DING Yan-sheng,LI Kang,SHENG Qin-hui,JIANG Jie,WANG Yu-chuan,SHI Li-bin
DOI: https://doi.org/10.3969/j.issn.1004-8812.2012.02.007
2012-01-01
Abstract:Objective To investigate the experience with an active fixation coronary sinus lead for cardiac resynchronization therapy ( CRT) . Methods A total number of 5 patients were implanted with Medtronic StarFix active fixation LV lead for CRT. Based on standard CRT techniques,the active fixation coronary sinus leads were implanted to the target veins and the lobes were deployed for fixation. The thresholds were measured and no phrenic nerve stimulation were verified. Patients were followed up for the improvement of cardiac function and to check if there were any loss of capture,unacceptable pacing thresholds,or diaphragmatic stimulation. Results All the patients were successful for the use of the active fixation LV leads and were placed in a nonanterior position. Pacing threshold were averaged ( 1. 3 ± 0. 7) V, amplitude of R wave were ( 7. 9 ± 2. 9) mV in averaged. During follow up,LVDd was decreased from ( 7. 43 ± 0. 87) cm to ( 7. 15 ± 0. 76) cm,LVEF was increased from 28. 8% ± 2. 8% to 36. 0% ± 4. 0% ,PAPs decreased from ( 51. 0 ± 20. 6) mm Hg to ( 24. 6 ± 2. 6) mm Hg,mitral regurgitation decreased individually. After 6 - 16 months of follow up,all the cardiac functions were improved with one grade of reduction for the NYHA classification. No patient has any loss of capture,unacceptable pacing thresholds,or diaphragmatic stimulation. Conclusions The Medtronic 4195 is safe and highly efficacious. It affers more choices in lead placement location and has a remarkably reduction of dislodgement rate and diaphragmatic stimulation rate.
What problem does this paper attempt to address?